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Intracellular glucose switches between cyclic ADP-ribose and
inositol trisphosphate triggering of cytosolic Ca2+ spiking
Jose M. Cancela*, Hideo Mogami, Alexei V. Tepikin and Ole H. Petersen
Cyclic ADP-ribose (cADPR) is a potentially important
intracellular Ca2+ releasing messenger [1–5]. In
pancreatic acinar cells where intracellular infusion of
both inositol trisphosphate (IP3) and cADPR evoke
repetitive Ca2+ spiking [6], the cADPR antagonist 8-NH2-
cADPR [7], which blocks cADPR-evoked but not IP3-
evoked Ca2+ spiking, can abolish Ca2+ spiking induced
by physiological levels of the peptide hormone
cholecystokinin (CCK) [8]. We have tested the effect of
intracellular glucose on the ability of IP3, cADPR and
CCK to induce cytosolic Ca2+ spikes in pancreatic acinar
cells. In order to gain access to the intracellular cytosol,
we used the whole-cell configuration of the patch-clamp
technique [9] and monitored cytosolic Ca2+ concentration
changes by measuring the Ca2+-dependent ionic current
[10–13]. Glucose (300mM to 10 mM) in the patch
pipette/intracellular solution prevented cADPR from
evoking Ca2+ spiking. The same effect was observed with
2-deoxy-glucose, but not L-glucose. In contrast, glucose
potentiated IP3-evoked Ca2+ spiking. CCK evoked Ca2+
spiking irrespective of the presence or absence of
intracellular glucose, but the cADPR antagonist 8-NH2-
cADPR blocked CCK-evoked Ca2+ spiking only in the
absence of intracellular glucose. This suggests that the
hormone can evoke Ca2+ spiking via either the IP3 or the
cADPR pathway. The intracellular glucose level may
control a switch between these two pathways.
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Results and discussion
The effect of cADPR in the absence of glucose in the
intracellular pipette solution
The short-lasting spikes of Ca2+-dependent Cl– and
monovalent cation current evoked by IP3 or cADPR in
pancreatic acinar cells are due to short-lasting elevations of
the cytoplasmic Ca2+ concentration specifically in the
apical granular area of the pancreatic acinar cells [6,13]. It
has previously been shown that cADPR evoked Ca2+
spiking when present in the pipette solution in concentra-
tions of 1 or 10 µM [6]. We stimulated 49 cells with either
1 or 10 µM cADPR, and 44 of these responded with repet-
itive spikes of Ca2+-dependent current (Figure 1); five
cells did not respond. Thus, about 90% of our cells were
sensitive to cADPR.
Intracellular glucose inhibits cADPR-evoked Ca2+ spiking
When 10 mM glucose (Sigma) was included in the pipette
solution, cADPR (10 µM) failed to induce responses in all
of the 14 cells tested, whereas in the control cells (without
glucose) from the same preparations, investigated in paral-
lel, five out of seven cells displayed cADPR responses
(Figure 1).
We also tried two very pure preparations of glucose (Sigma-
ultra and Aristar). In four cells with 10 mM glucose (Sigma-
ultra), cADPR failed to evoke any response, whereas in
three out of the four control cells, responses to cADPR
were found (Figure 1). Of the seven cells investigated with
10 mM glucose (Aristar) and cADPR in the pipette solu-
tion, five cells failed to spike, whereas two did. In the
seven control cells, six responded whereas one did not. In
the total of 25 experiments with 10 mM glucose and 10 µM
cADPR in the pipette solution, only two cells presented
repetitive spikes, most likely of a spontaneous nature.
We also used lower glucose concentrations. At 2.5 mM
there were no responses to cADPR in the eight cells
tested, whereas all four control cells generated spikes. At a
glucose concentration of 1 mM, seven out of nine cells
failed to respond, whereas all six control cells were able to
fire spikes. At 300 µM all six cells investigated failed to
evoke spikes whereas all five control cells responded nor-
mally to cADPR (Figure 1). When 100 µM glucose was
present in the pipette solution, three out of five cells
failed to respond whereas two did. In the corresponding
control series, five cells fired spikes whereas one did not.
At a glucose concentration of 30 µM, four out of six cells
responded (Figure 1) and two cells failed to generate
spikes. In the corresponding control series, all six cells
responded. The effect of intracellular glucose was there-
fore difficult to detect below 100 µM (Figure 1).
There is little information about intracellular glucose con-
centrations in living cells. In single cardiac myocytes, the
intracellular glucose concentration reached 60% of the
extracellular glucose concentration in the presence of
insulin [14]. Cells may therefore have millimolar levels of
glucose intracellularly. In the absence of insulin, the intra-
cellular glucose concentration is much lower and is hardly
influenced by the extracellular glucose concentration [14].
Considering that the Km for hexokinase is about 30 µM
[14], the intracellular glucose concentration could vary
markedly, depending on the insulin concentration, from a
few micromolar to a few millimolar. Fluctuations of intra-
cellular glucose in this range could have an important mod-
ulatory action on agonist-evoked Ca2+ signal generation.
To test whether glucose metabolism was essential for the
inhibitory effect on cADPR-evoked Ca2+ spiking, we per-
formed experiments with the stable analogue 2-deoxy-
glucose. In nine whole-cell recording experiments with
10 mM 2-deoxy-glucose in the pipette solution, cADPR
consistently failed to evoke spiking whereas the four
control cells all responded with repetitive spikes (Figure 2).
The inhibitory effects so far described were due to D-
glucose. When 10 mM L-glucose was present in the pipette
solution, five out of eight cells displayed normal responses
to cADPR (Figure 2). In the corresponding control series,
all eight cells tested responded to cADPR. Clearly L-
glucose does not block cADPR-induced Ca2+ spiking.
Glucose was always present in the external solution. At
room temperature and patch-clamp whole-cell recording
(dialysis of intracellular space with pipette solution), glucose
entry across the plasma membrane seems insufficient to
have any effect on the cytoplasmic glucose level, which is
clamped by the glucose concentration in the pipette solu-
tion. This was confirmed in three experiments in which we
increased the external glucose concentration from 5 to
45 mM without glucose inside the pipette. In each of these
three experiments, cADPR evoked spiking, which was not
inhibited by the external glucose concentration.
Intracellular glucose potentiates IP3-evoked cytosolic Ca2+
spiking
Figure 3 shows typical spiking responses to 10 µM 2,4,5-
IP3 — a non-metabolizable IP3 analogue. In all of the five
cells that were internally perfused with 10 mM glucose,
there were vigorous responses. Of the five control cells (no
glucose in pipette solution), four displayed clear responses
(Figure 3) whereas one failed to respond. The higher
spike frequency and larger amplitude of the spikes in the
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Figure 2
Intracellular 2-deoxy-glucose inhibits cADPR-evoked Ca2+ spiking,
whereas L-glucose has no effect. In all cases cADPR (10 µM) was
present in the internal pipette solution. Control traces are on the left
side. When 2-deoxy-glucose (10 mM) was in the internal pipette
solution, cADPR failed to evoke spikes whereas 10 mM L-glucose in
the pipette solution had no inhibitory effect.
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Figure 1
Intracellular glucose inhibits cADPR-evoked Ca2+ spiking. Each pair of
traces represents recordings from single cells obtained from the same
batch tested in parallel. In all cases, cADPR (10 µM) was present in
the patch pipette/intracellular solution. Glucose was present in the
pipette/intracellular solution as indicated in the stated concentration.
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presence of glucose, seen in Figure 3, are typical. In a
second series with 10 mM glucose intracellularly, the
initial response to 10 µM 2,4,5-IP3 was a very broad tran-
sient followed by high-frequency spiking (five out of six
cells; Figure 3). Such initial broad responses have never
been observed in the absence of intracellular glucose. We
also tested the effect of 2-deoxy-glucose. Nine cells were
internally perfused with 10 mM 2-deoxy-glucose and
10 µM 2,4,5-IP3. In seven cases, there were clear
responses (Figure 3) whereas two cells failed to respond.
Of the 10 control cells, seven responded normally
(Figure 3) whereas three remained silent. There was no
difference between the spike pattern in the presence or
absence of 2-deoxy-glucose.
Effects of intracellular glucose and the cADPR antagonist
8-NH2-cADPR on CCK-evoked Ca2+ spiking
In some of our previous patch-clamp whole-cell current
recording studies of CCK-evoked Ca2+ spikes, glucose
(10 mM) was included in the internal pipette solution and
this did not prevent spiking responses [15,16]. In other
studies, glucose was not present in the pipette solution,
but in these cases CCK did also evoke spiking [13,17].
The involvement of cADPR receptors in Ca2+ signal gen-
eration can be tested using a cADPR antagonist. The
cADPR antagonist 8-NH2-cADPR [7] inhibits Ca2+ signal
generation in, for example, sea urchin eggs [18] and heart
muscle [19]. In the absence of intracellular glucose, 8-
NH2-cADPR abolishes Ca2+ spiking in pancreatic acinar
cells evoked by a physiological CCK concentration (5 pM)
[8] indicating that cADPR receptors play a role and that at
this physiological hormone concentration with low internal
glucose there is insufficient IP3 receptor activation to gen-
erate Ca2+ spikes. We have now compared the effect of this
cADPR antagonist on the CCK-evoked response in the
presence and absence of 10 mM glucose in the internal
solution. In the absence of intracellular glucose the Ca2+
spiking evoked by 5 pM CCK was, as previously shown
[8], abolished by inclusion of 18 µM 8-NH2-cADPR in the
pipette solution (Figure 4), but in the presence of glucose
the antagonist failed to block the CCK response (Figure 4).
In the four control experiments, CCK (5 pM) evoked the
usual response. In five out of seven experiments with the
antagonist, the cells responded to CCK (5 pM) with long
transients and few short-lasting spikes (Figure 4).
The cADPR antagonist does not block IP3-evoked
responses [8]. CCK responses are blocked by heparin,
used as a IP3 receptor antagonist, in the presence of intra-
cellular glucose [16]. In the absence of intracellular
glucose, the CCK response seems dominated by Ca2+
release from cADPR receptors, whereas at a high intracel-
lular glucose concentration it may be mainly due to activa-
tion of IP3 receptors. Isolated liver nuclei can release Ca2+
from the nuclear envelope store in response to both IP3
and cADPR [20], and isolated zymogen granules from
pancreatic acinar cells also release Ca2+ in response to
either of these messengers [21]. Both these sets of experi-
ments [20,21] were carried out in glucose-free solutions.
CCK stimulates glucose entry in pancreatic acinar cells
[22] and potentiates CCK-induced amylase secretion [23],
partly due to insulin release [24]. The IP3-evoked Ca2+
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Figure 3
Intracellular glucose potentiates IP3-evoked Ca2+ spiking. 2,4,5-IP3
(10 µM) was present in the patch pipette/intracellular solution in each
experiment. Glucose or 2-deoxy-glucose was present in the
pipette/intracellular solution as indicated.
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Figure 4
The cADPR antagonist 8-NH2-cADPR inhibits CCK-evoked Ca2+
spiking in the absence of intracellular glucose but fails to inhibit when
glucose is present intracellularly. The control traces (left) show the
normal effects of CCK (5 pM) in the absence or presence of glucose
intracellularly. In the absence of intracellular glucose (top) 8-NH2-cADPR
(18 µM), when present in the internal pipette solution, blocks the CCK-
induced response. In the presence of glucose (10 mM) intracellularly,
the cADPR antagonist fails to block the CCK response (bottom).
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spiking is enhanced by glucose (Figure 3). The inhibitory
effect of the cADPR antagonist on the CCK response, in
the absence of glucose, can be overcome by increasing the
CCK concentration [8]. CCK-evoked glucose entry may
stimulate the IP3 receptors.
The opposite effects of intracellular glucose on cADPR-
evoked and IP3-evoked Ca2+ spiking (Figures 1 and 3)
taken together with the ability of 8-NH2-cADPR to block
CCK-evoked Ca2+ signals in the absence but not presence
of intracellular glucose (Figure 4) suggest that fluctuations
of intracellular glucose could modulate agonist-evoked
Ca2+ signal generation acting as a switch control between
cADPR and IP3 receptors. The precise spatio-temporal
pattern of cytosolic Ca2+ spiking is very dependent on
agonist type and concentration as well as passive and
active Ca2+ buffering [15,25,26], but the mechanisms
underlying these phenomena [26] are obscure. The physi-
ological importance of the glucose-controlled switch may
be due to subtly different subcellular localizations of IP3
and cADPR receptors. The internal glucose effect
reported here could become a useful tool in further inves-
tigations aimed at elucidating the relative importance of
different Ca2+ signalling pathways.
Materials and methods
Isolated single and double mouse pancreatic acinar cells were pre-
pared by pure collagenase (100 U/ml; Worthington Biochemical Corp)
digestion in the presence of trypsin inhibitor (3.5 mg/ml Sigma) as
described previously [6,12]. The cells were investigated using the
whole-cell patch-clamp configuration at room temperature. From a
holding potential of –30 mV, steps were made to 0 mV, the reversal
potential of the two Ca2+-dependent currents [12]. These Ca2+-depen-
dent channel currents were used to monitor cytosolic Ca2+ concentra-
tion changes [11,13,15]. The extracellular Na+-rich solution contained
140 mM NaCl, 4.7 mM KCl, 1.13 mM MgCl2, 5 or 10 mM glucose,
1 mM CaCl2 and 10 mM HEPES-NaOH pH 7.2. CCK octapeptide was
added to the external solution as indicated. 2,4,5-IP3, 2-deoxy-glucose,
D-glucose, D-glucose (Sigma-ultra), L-glucose (Sigma), D-glucose
(Aristar; Merck), cADPR and 8-NH2-cADR (Molecular Probes) were
added, as required to the intracellular (patch-clamp pipette) solution.
The internal solution contained 140 mM KCl, 1.13 mM MgCl2,
0.05 mM EGTA, 2 mM ATP and 10 mM HEPES-KOH pH 7.2.
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